Orphazyme A's ROA from the fourth quarter of 2021 to the fourth quarter of 2020 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Orphazyme A's ROA in the fourth quarter of 2021?
Orphazyme A recorded a cumulative net loss of $-100 million during 12 months ending in the fourth quarter of 2021, resulting in a negative return on assets (ROA) of -21.75%.

However, within the Healthcare sector 1172 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2021 from to 5947.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2021) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2020) IV. Quarter
Y / Y Total Assets Change	-96.79 %	496.47 %	-	-	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-100	-97	-97	-97	-97
Return On Assets (TTM)	-21.75 %	-14.75 %	-15.54 %	-23.19 %	-45.64 %
ORPH's Total Ranking	# 5947	#	#	#	#
Total Assets (TTM) in million	26	162	822	822	822
Seq. Total Assets Change	-83.72 %	-80.3 %	0 %	0 %	2928.44 %
Seq. Net Income Change	-	-	-	-	-

ORPH's 5 Years Annual ROA >> Back to ORPH Management Effectiveness >> Compare ORPH ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 601
Sector	# 1173
Overall	# 5805

Return On Assets Statistics
High	Average	Low
-361.68 %	-361.68 %	-361.68 %
(Dec 31 2021)

Financial Statements
Orphazyme A's Assets	$ 26 million	ORPH's Balance sheet
Orphazyme A's Income	$ -100 million	Quarterly ORPH's Income Statement
ORPH's Income by Division		See ORPH's Income by Division

Annual Return On Assets	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020	FY	FY	FY
Y / Y Total Assets Change	-78.94 %	-	-	-	-
Total Assets in million	173	822	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-627	-633	0	0	0
Annual Return On Assets	-361.68 %	-76.99 %	-	-	-

ORPH's 5 Years Annual ROA >> Back to ORPH Management Effectiveness >> Compare ORPH ROA to its Competitors

More Return On Assets Ratios
ORPH's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ORPH's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ORPH's Competitors
Subscribers only: Roa for Orphazyme A's Suppliers
Subscribers only: Return On Assets for ORPH's Customers

You may also want to know
ORPH's Roi	ORPH's Inventory Turnover Ratio	ORPH's Growth Rates	ORPH's Dividend Comparisons
	ORPH's Profitability Ratios	ORPH's Asset Turnover Ratio	ORPH's Dividend Growth
ORPH's Roe	ORPH's Valuation Ratios	ORPH's Financial Strength Ratios	ORPH's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2021, within Healthcare Sector

ROA

Date modified: 2026-09-18T13:11:04+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.